Publication | Closed Access

Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel

Comprehensive Pharmacogenetic AnalysisOncologyPancreatic CancerMedicineAbcb1 PolymorphismsPathologyPancreatic Cancer PatientsCancer GenomicsPharmacologyRadiation OncologyCancer Research